Related Experiment Video
Updated: Jan 18, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Pharmacists' Interventions in Virtual Diabetes Clinics: Cost-Effectiveness Feasibility Study
Sinaa Al-Aqeel1, Alaa Mutlaq2, Njood Alkhalifa1
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Healthcare (Basel, Switzerland)
|September 13, 2025
Summary
Pharmacists effectively managed diabetes patients via virtual clinics, providing education and counseling. Data collection for future cost-effectiveness studies showed feasibility but highlighted challenges with patient outcome data.
Area of Science:
- Pharmacology
- Digital Health
- Healthcare Management
Background:
- Telepharmacy enhances diabetes care and healthcare access.
- Virtual pharmacist-led diabetes clinics (PLDC) offer remote patient management.
- This study focuses on interventions and feasibility in a virtual setting.
Purpose of the Study:
- Characterize pharmacist interventions in a virtual PLDC.
- Assess feasibility for future cost-effectiveness studies of PLDCs.
- Evaluate the role of telepharmacy in diabetes management.
Main Methods:
- Prospective observational feasibility study.
- Data collected by intern pharmacists at Seha Virtual Hospital.
- Patient data gathered via telephone consultations.
Main Results:
- 75 patients (58.7% female, 86.6% type 2 diabetes) participated.
- 179 interventions performed, primarily patient education and counseling.
- Feasible data capture for interventions, but patient outcome data was incomplete.
Conclusions:
- Pharmacists effectively identify and manage diabetes issues in virtual PLDCs.
- Feasibility for cost-effectiveness studies confirmed, with identified challenges.
- Virtual PLDCs demonstrate potential for diabetes care delivery.
More Related Videos
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
870
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870
01:29Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
01:24Dosage Regimen: Individualization
167
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
167
01:16Therapeutic Drug Monitoring: Overview and Classification
315
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
315